Sign in
CompletedPhase 4

Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
90 people enrolled
Started
17 Oct 2023
Ended
5 Nov 2024
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 0.9% sodium chloride
  • Dexamethasone
  • Dexmedetomidine
Record updated
21 January 2025

Who can take part

Age
10 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • children scheduled for idiopathic scoliosis surgery
  • age >10 and <18 years

Who cannot take part

  • steroid medication in regular use
  • infection at the site of the regional blockade
  • coagulation disorders
  • age < 10 years
  • age < 18 years
  • immunodeficiency
  • ASA= or >4

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for pediatric, idiopathic scoliosis surgery.

The 3 groups in the trial

  • PlaceboPlacebo, for comparison

    0.2% ropivacaine for erector spinae plane block

    Treatment: 0.9% sodium chloride

  • DexamethasoneExisting treatment, for comparison

    0.2% ropivacaine + 0.1mg/kg Dexamethasone for erector spinae plane block

  • DexmedetomidineExisting treatment, for comparison

    0.2% ropivacaine + 0.1ug/kg Dexmedetomidine for erector spinal plane block

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dexamethasone Vs. Dexmedetomidine for Erector Spine Plane Block in Pain Management After Pediatric Idiopathic Scoliosis Surgery.
Record updated
21 January 2025